Table 2.
Description
|
Indicator
|
References
|
Procurement efficiency | The ratio between the median price of medicines procured and the international median reference value (target ≤1) | WHO (2011). Harmonized Monitoring and Evaluation Indicators for Procurement and Supply Management Systems: Early-Warning Indicators to Prevent Stock-Outs and Overstocking of Antiretroviral, Antituberculosis and Antimalarial Medicines |
Availability | Percentage of items available per total number of NMSF items | *MSH. MDS-3: Managing Access to Medicines and Health Technologies. 3rd ed. West Hartford, CT: Kumarian Press; 2013 |
*WHO (2011). Harmonized Monitoring and Evaluation Indicators for Procurement and Supply Management Systems: Early-Warning Indicators to Prevent Stock-Outs and Overstocking of Antiretroviral, Antituberculosis and Antimalarial Medicines | ||
Coverage | Percentage of coverage of NMSF services among public institutions | WHO (2007). Operational package for assessing, monitoring, and evaluating country pharmaceutical situations |
Improving capacity building | Number of staff responsible for PSM who have been trained in PSM | WHO (2008). Harmonized Monitoring and Evaluation Indicators for ARV Procurement and Supply Management Systems |
MSH, Managment Sciences for Health; NMSF, National Medical Supplies Fund; WHO, World Health Organization